Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
An Integrative Review of Curricular Considerations for Preparing Student Pharmacists to Prescribe Hormonal Contraception

Build and Broaden 3.0 AND Program Evaluation

Cieri-Hutcherson NE, Stone RH, Vernon V.
GSID: x3KkeA-uygAJ
RH Stone, NE Cieri-Hutcherson, V Vernon… - American Journal of …, 2021 - ajpe.org

Starting in 2014, the pharmacist's role in the United States (US) has expanded to include prescribing hormonal contraception (HC), and is currently addressed with policy in 14 states and Washington DC. Training and education requirements for this expanded scope...

Cite
Stone, R. H., Cieri-Hutcherson, N. E., Vernon, V., Arellano, R., Mospan, C., Harris, J. B., ... & Vest, K. (2021). An Integrative Review of Curricular Considerations for Preparing Student Pharmacists to Prescribe Hormonal Contraception. American Journal of Pharmaceutical Education.
Stone, Rebecca H., et al. "An Integrative Review of Curricular Considerations for Preparing Student Pharmacists to Prescribe Hormonal Contraception." American Journal of Pharmaceutical Education (2021).
Copy Download .nbib Format: MLA
Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge.

Pharmacy (Basel, Switzerland)

Warunek LN, Cieri-Hutcherson NE, Kersten BP, Hassan AK.
PMID: 34941634
Pharmacy (Basel). 2021 Dec 16;9(4). doi: 10.3390/pharmacy9040202.

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity, mortality, and reduced quality of life for patients. Proper use of inhaler devices is critical for effective drug delivery and prevention of COPD progression. The primary...

Cite
Warunek LN, Cieri-Hutcherson NE, Kersten BP, et al. Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge. Pharmacy (Basel). 2021;9(4)doi: 10.3390/pharmacy9040202.
Warunek, L. N., Cieri-Hutcherson, N. E., Kersten, B. P., & Hassan, A. K. (2021). Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge. Pharmacy (Basel, Switzerland), 9(4), . https://doi.org/10.3390/pharmacy9040202
Warunek, Letitia N, et al. "Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge." Pharmacy (Basel, Switzerland) vol. 9,4 (2021). doi: https://doi.org/10.3390/pharmacy9040202
Warunek LN, Cieri-Hutcherson NE, Kersten BP, Hassan AK. Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge. Pharmacy (Basel). 2021 Dec 16;9(4). doi: 10.3390/pharmacy9040202. PMID: 34941634; PMCID: PMC8706204.
Copy Download .nbib Format: NLM
Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge.

Pharmacy (Basel, Switzerland)

Warunek LN, Cieri-Hutcherson NE, Kersten BP, Hassan AK.
PMID: 34941634
Pharmacy (Basel). 2021 Dec 16;9(4). doi: 10.3390/pharmacy9040202.

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity, mortality, and reduced quality of life for patients. Proper use of inhaler devices is critical for effective drug delivery and prevention of COPD progression. The primary...

Cite
Warunek LN, Cieri-Hutcherson NE, Kersten BP, et al. Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge. Pharmacy (Basel). 2021;9(4)doi: 10.3390/pharmacy9040202.
Warunek, L. N., Cieri-Hutcherson, N. E., Kersten, B. P., & Hassan, A. K. (2021). Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge. Pharmacy (Basel, Switzerland), 9(4), . https://doi.org/10.3390/pharmacy9040202
Warunek, Letitia N, et al. "Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge." Pharmacy (Basel, Switzerland) vol. 9,4 (2021). doi: https://doi.org/10.3390/pharmacy9040202
Warunek LN, Cieri-Hutcherson NE, Kersten BP, Hassan AK. Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge. Pharmacy (Basel). 2021 Dec 16;9(4). doi: 10.3390/pharmacy9040202. PMID: 34941634.
Copy Download .nbib Format: NLM
Evidence for Idarucizumab (Praxbind) in the Reversal Of the Direct Thrombin Inhibitor Dabigatran: Review Following the RE-VERSE AD Full Cohort Analysis.

P & T : a peer-reviewed journal for formulary management

Hutcherson TC, Cieri-Hutcherson NE, Bhatt R.
PMID: 29089725
P T. 2017 Nov;42(11):692-698.

Idarucizumab is the first reversal agent approved for the direct thrombin inhibitor dabigatran. The authors summarize the findings from the clinical trial series and describe case reports, post-marketing data, and ongoing studies.

Cite
Hutcherson TC, Cieri-Hutcherson NE, Bhatt R. Evidence for Idarucizumab (Praxbind) in the Reversal Of the Direct Thrombin Inhibitor Dabigatran: Review Following the RE-VERSE AD Full Cohort Analysis. P T. 2017;42(11):692-698
Hutcherson, T. C., Cieri-Hutcherson, N. E., & Bhatt, R. (2017). Evidence for Idarucizumab (Praxbind) in the Reversal Of the Direct Thrombin Inhibitor Dabigatran: Review Following the RE-VERSE AD Full Cohort Analysis. P & T : a peer-reviewed journal for formulary management, 42(11), 692-698.
Hutcherson, Timothy C, et al. "Evidence for Idarucizumab (Praxbind) in the Reversal Of the Direct Thrombin Inhibitor Dabigatran: Review Following the RE-VERSE AD Full Cohort Analysis." P & T : a peer-reviewed journal for formulary management vol. 42,11 (2017): 692-698.
Hutcherson TC, Cieri-Hutcherson NE, Bhatt R. Evidence for Idarucizumab (Praxbind) in the Reversal Of the Direct Thrombin Inhibitor Dabigatran: Review Following the RE-VERSE AD Full Cohort Analysis. P T. 2017 Nov;42(11):692-698. PMID: 29089725; PMCID: PMC5642158.
Copy Download .nbib Format: NLM
Systematic Review of l-Arginine for the Treatment of Hypoactive Sexual Desire Disorder and Related Conditions in Women.

Pharmacy (Basel, Switzerland)

Cieri-Hutcherson NE, Jaenecke A, Bahia A, Lucas D, Oluloro A, Stimmel L, Hutcherson TC.
PMID: 33801678
Pharmacy (Basel). 2021 Mar 27;9(2). doi: 10.3390/pharmacy9020071.

This systematic review evaluates the efficacy and safety of l-arginine alone or in combination for the treatment of women with hypoactive sexual desire disorder (HSDD) or related conditions, such as female sexual interest/arousal disorder and female sexual arousal disorder....

Cite
Cieri-Hutcherson NE, Jaenecke A, Bahia A, et al. Systematic Review of l-Arginine for the Treatment of Hypoactive Sexual Desire Disorder and Related Conditions in Women. Pharmacy (Basel). 2021;9(2)doi: 10.3390/pharmacy9020071.
Cieri-Hutcherson, N. E., Jaenecke, A., Bahia, A., Lucas, D., Oluloro, A., Stimmel, L., & Hutcherson, T. C. (2021). Systematic Review of l-Arginine for the Treatment of Hypoactive Sexual Desire Disorder and Related Conditions in Women. Pharmacy (Basel, Switzerland), 9(2), . https://doi.org/10.3390/pharmacy9020071
Cieri-Hutcherson, Nicole E, et al. "Systematic Review of l-Arginine for the Treatment of Hypoactive Sexual Desire Disorder and Related Conditions in Women." Pharmacy (Basel, Switzerland) vol. 9,2 (2021). doi: https://doi.org/10.3390/pharmacy9020071
Cieri-Hutcherson NE, Jaenecke A, Bahia A, Lucas D, Oluloro A, Stimmel L, Hutcherson TC. Systematic Review of l-Arginine for the Treatment of Hypoactive Sexual Desire Disorder and Related Conditions in Women. Pharmacy (Basel). 2021 Mar 27;9(2). doi: 10.3390/pharmacy9020071. PMID: 33801678; PMCID: PMC8103282.
Copy Download .nbib Format: NLM
Pharmacists and Contraception in the Inpatient Setting.

Pharmacy (Basel, Switzerland)

Ciriello D, Cieri-Hutcherson N.
PMID: 32397460
Pharmacy (Basel). 2020 May 09;8(2). doi: 10.3390/pharmacy8020082.

The choice of contraceptive method should be based on patient specific factors, patient preference, and method-specific properties. In this article, we review opportunities for an inpatient clinical pharmacist to assist in the selection and counseling of contraceptives in hospitalized...

Cite
Ciriello D, Cieri-Hutcherson N. Pharmacists and Contraception in the Inpatient Setting. Pharmacy (Basel). 2020;8(2)doi: 10.3390/pharmacy8020082.
Ciriello, D., & Cieri-Hutcherson, N. (2020). Pharmacists and Contraception in the Inpatient Setting. Pharmacy (Basel, Switzerland), 8(2), . https://doi.org/10.3390/pharmacy8020082
Ciriello, Domenique, and Cieri-Hutcherson, Nicole. "Pharmacists and Contraception in the Inpatient Setting." Pharmacy (Basel, Switzerland) vol. 8,2 (2020). doi: https://doi.org/10.3390/pharmacy8020082
Ciriello D, Cieri-Hutcherson N. Pharmacists and Contraception in the Inpatient Setting. Pharmacy (Basel). 2020 May 09;8(2). doi: 10.3390/pharmacy8020082. PMID: 32397460; PMCID: PMC7356798.
Copy Download .nbib Format: NLM
Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge.

Pharmacy (Basel, Switzerland)

Warunek LN, Cieri-Hutcherson NE, Kersten BP, Hassan AK.
PMID: 34941634
Pharmacy (Basel). 2021 Dec 16;9(4). doi: 10.3390/pharmacy9040202.

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity, mortality, and reduced quality of life for patients. Proper use of inhaler devices is critical for effective drug delivery and prevention of COPD progression. The primary...

Cite
Warunek LN, Cieri-Hutcherson NE, Kersten BP, et al. Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge. Pharmacy (Basel). 2021;9(4)doi: 10.3390/pharmacy9040202.
Warunek, L. N., Cieri-Hutcherson, N. E., Kersten, B. P., & Hassan, A. K. (2021). Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge. Pharmacy (Basel, Switzerland), 9(4), . https://doi.org/10.3390/pharmacy9040202
Warunek, Letitia N, et al. "Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge." Pharmacy (Basel, Switzerland) vol. 9,4 (2021). doi: https://doi.org/10.3390/pharmacy9040202
Warunek LN, Cieri-Hutcherson NE, Kersten BP, Hassan AK. Interventional, Quasi-Experimental Study of a Chronic Obstructive Pulmonary Disease Education Care Plan for Hospital Discharge. Pharmacy (Basel). 2021 Dec 16;9(4). doi: 10.3390/pharmacy9040202. PMID: 34941634.
Copy Download .nbib Format: NLM
Systematic Review of Black Cohosh (.

Journal of pharmacy practice

Fan CW, Cieri-Hutcherson NE, Hutcherson TC.
PMID: 33926292
J Pharm Pract. 2021 Apr 29;8971900211012244. doi: 10.1177/08971900211012244. Epub 2021 Apr 29.

Polycystic ovary syndrome (PCOS) is a common cause of female infertility. To conduct a systematic review assessing the efficacy and safety of black cohosh for ovulation-induction through hormone regulation and increased endometrial thickness to improve pregnancy rates in women...

Cite
Fan CW, Cieri-Hutcherson NE, Hutcherson TC. Systematic Review of Black Cohosh (. J Pharm Pract. 2021;8971900211012244doi: 10.1177/08971900211012244.
Fan, C. W., Cieri-Hutcherson, N. E., & Hutcherson, T. C. (2021). Systematic Review of Black Cohosh (. Journal of pharmacy practice, 8971900211012244. https://doi.org/10.1177/08971900211012244
Fan, Chi Wai, et al. "Systematic Review of Black Cohosh (." Journal of pharmacy practice vol. (2021): 8971900211012244. doi: https://doi.org/10.1177/08971900211012244
Fan CW, Cieri-Hutcherson NE, Hutcherson TC. Systematic Review of Black Cohosh (. J Pharm Pract. 2021 Apr 29;8971900211012244. doi: 10.1177/08971900211012244. Epub 2021 Apr 29. PMID: 33926292.
Copy Download .nbib Format: NLM
An Integrative Review of Curricular Considerations for Preparing Student Pharmacists to Prescribe Hormonal Contraception.

American journal of pharmaceutical education

Stone RH, Cieri-Hutcherson NE, Vernon V, Arellano R, Mospan C, Harris JB, Barnes KN, Griffin BL, Lodise NM, Patel J, Rafie S, Vest K.
PMID: 34385172
Am J Pharm Educ. 2021 Aug 12;8667. doi: 10.5688/ajpe8667. Epub 2021 Aug 12.

Starting in 2014, the pharmacist's role in the United States (US) has expanded to include prescribing hormonal contraception (HC), and is currently addressed with policy in 14 states and Washington D.C.. Training and education requirements for this expanded scope...

Cite
Stone RH, Cieri-Hutcherson NE, Vernon V, et al. An Integrative Review of Curricular Considerations for Preparing Student Pharmacists to Prescribe Hormonal Contraception. Am J Pharm Educ. 2021;8667doi: 10.5688/ajpe8667.
Stone, R. H., Cieri-Hutcherson, N. E., Vernon, V., Arellano, R., Mospan, C., Harris, J. B., Barnes, K. N., Griffin, B. L., Lodise, N. M., Patel, J., Rafie, S., & Vest, K. (2021). An Integrative Review of Curricular Considerations for Preparing Student Pharmacists to Prescribe Hormonal Contraception. American journal of pharmaceutical education, 8667. https://doi.org/10.5688/ajpe8667
Stone, Rebecca H, et al. "An Integrative Review of Curricular Considerations for Preparing Student Pharmacists to Prescribe Hormonal Contraception." American journal of pharmaceutical education vol. (2021): 8667. doi: https://doi.org/10.5688/ajpe8667
Stone RH, Cieri-Hutcherson NE, Vernon V, Arellano R, Mospan C, Harris JB, Barnes KN, Griffin BL, Lodise NM, Patel J, Rafie S, Vest K. An Integrative Review of Curricular Considerations for Preparing Student Pharmacists to Prescribe Hormonal Contraception. Am J Pharm Educ. 2021 Aug 12;8667. doi: 10.5688/ajpe8667. Epub 2021 Aug 12. PMID: 34385172.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries